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Abstract 
BACKGROUND: Basal cell carcinoma belongs to non-melanoma skin cancers and is the most prevalent 
neoplasia that shows a tendency to increase over the last few decades. It occurs most often in skin areas 
exposed to sunlight. It is characterised by slow progression, low tendency to metastasising and good prognosis 
when the right choice of treatment has been made. The difficulty in the treatment of basal cell carcinomas is 
determined by their localisation and puts to the test the aesthetic potential of dermatosurgeons. Complete surgical 
excision is the standard approach in most uncomplicated cases. In relapsing basal cell carcinoma or carcinoma 
with aggressive or unfavourable histopathological characteristics, the clinician faces the dilemma of identifying the 
most appropriate method of treatment. To find the decision, help comes from the individualisation of each case 
and the related risk factors.  
CASE REPORT: Two cases of basal cell carcinoma of similar localisation are presented, where the carcinomas 
are removed using island flaps. In spite of the desire to observe the recommended field of surgical security (by the 
desire for the ultimate esthetic effect for the patient), one of the tumours was not completely removed, and as an 
alternative, reoperation was proposed using Mohs micrographic surgery (MMS).  
CONCLUSION: The choice of a surgical technique, which would guarantee a better outcome and could be 
applied depending on the individual risk factor in each patient, is discussed. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Basal cell carcinoma is the most common 
malignant tumour composed of cells resembling those 
of the basal layer of the epidermis [1]. The disease 
rate is 200/100.000 people on the average [2] [3]. The 
affection of patients with white skin, fair hair and blue 
eyes, as well as male patients, prevails [4] [5]. It is 
believed that the main reason for its occurrence is the 
long-term exposure to sunlight over the patient’s 
lifetime or accidental intensive exposure to ultraviolet 
radiation resulting in skin burns [4] [5]. It usually 
affects the exposed areas of the skin, i.e. the face, 
scalp, ears, neck and shoulders [1]. This epidermal 
tumour rarely metastasises (only certain types), but in 
the presence of a primary lesion, there is a risk of 
occurrence of a new lesion at the same site or another 
part of the body [5] [6]. For this reason, surgical 
removal of the tumour should be a priority [6].  
We at this moment present two cases of basal 
cell carcinomas with a similar localisation in the area 
of the face, which are removed by island flap. In one 
of the patients, the tumour is completely removed, 
while in the other it is not. The applicability of island 
flap in various patients is discussed according to their 
risk profile. 
Case Report 
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Case Report 1 
 
An 82-year-old woman is presented, with 
height 156 cm and weight 49 kg, in a good overall 
condition. There is no evidence of family history, 
concomitant diseases and medication. The patient 
was first admitted to the clinic for surgical removal of a 
neoplasm that occurred approximately 2 years before, 
which gradually began to increase in the last few 
months. During the dermatological examination, we 
found a nodular formation on the left side of the nose, 
at the border with the nasolabial fold. The lesion had a 
rigid consistency, nodular, without a pearl edge, 
located immediately below the nasolabial fold, but at 
the same time involving the ala nasi on the left (Figure 
1a).  
 
Figure 1: The lesion was removed in the form of the letter O, with a 
comparatively small field of surgical security of 0.3 cm in all 
directions. Then contouring of a triangle in the distal direction from 
the nose was performed, and the contours were gradually prepared 
to the musculature in depth (1c-d). This was followed by a 
transposition of the already prepared triangle to the ala nasi and a 
careful adaptation of the wound edges (1e-g) 
 
There was no clinical evidence of the 
involvement of the subcutaneous area and the 
adjacent vascular and nerve bundles. Radical removal 
was performed under local anaesthesia via island flap 
(1b-h). The lesion was removed in the form of the 
letter O, with a comparatively small field of surgical 
security of 0.3 cm in all directions.  
 
Figure 2: The histological examination confirmed the diagnosis: 
basal cell carcinoma with free resection edges, size 0.6/0.4 cm 
(Figure 2a-d). Good cosmetic results were achieved (2h) 
Then contouring of a triangle in the distal 
direction from the nose was performed, and the 
contours were gradually prepared to the musculature 
in depth (1c-d). 
This was followed by a transposition of the 
already prepared triangle to the ala nasi and a careful 
adaptation of the wound edges (1e-g). The 
histological examination confirmed the diagnosis: 
basal cell carcinoma with free resection edges, size 
0.6/0.4 cm (Figure 2a-d). Good cosmetic results were 
achieved (2h). 
 
 
Case Report 2 
 
A 56-year-old man is presented, with height 
178 cm and weight 108kg, in a good overall condition. 
There is no evidence of family history. The patient 
was first admitted to the clinic for surgical removal of a 
tumorous formation in the nasal area. In 2006, the 
patient underwent a primary tumour surgery (a tumour 
was localised near the described one), and in 2014 
there was a relapse, and the patient was operated 
again using advanced plastic surgery. Histological 
data showed that the patient had basal cell carcinoma 
resected in sano. Meanwhile, radiotherapy was also 
conducted. 
 
Figure 3: Island flap in patient with recurrent BCC. Similar to case 1 
the the tumour lesion was removed, with a comparatively small field 
of surgical security in all directions. Then contouring of a triangle in 
the distal direction from the nose was performed, and the contours 
were gradually prepared to the musculature in depth (3b, 3c). This 
was followed by a transposition of the already prepared triangle to 
the ala nasi and a careful adaptation of the wound edges (3d). 
Histological evidence showed the presence of basal cell carcinoma 
with multifocal growth, maximum tumor diameter 12mm (Figs 3e-h) 
 
During the dermatological examination, a 
tumour formation was found, with a solid texture, 
similar nodular aspect (as in the first female patient 
described), a clear distinction from the 
healthy/surrounding tissue, with multiple 
telangiectasias, located above the ala nasi, in the area 
of the right nasolabial fold (Figure 3a). Following 
consultation with an ENT specialist, an involvement of 
the lateral nasal wall was observed, from a formation 
adjacent to a cicatrix from a previous intervention, 
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without adhesion to the underlying cartilage. Island 
flap was performed similarly to the one described for 
the first patient (3b-3d). Histological evidence showed 
the presence of basal cell carcinoma with multifocal 
growth, maximum tumor diameter 12 mm; tumor 
infiltration in-depth and along the lateral resection 
lines (Figure 3e-3h). Tumor remnants were planned 
for removal using Mohs micrographic surgery. 
 
 
Discussion 
 
Patients with basal cell carcinoma are 
susceptible to recurrence of a primary tumour but also 
to the development of new, not only basal cellular but 
also other types of carcinomas [7]. Therefore, the 
identification of additional risk factors is, on the one 
hand, 1) essential for calculating the individual risk for 
each patient, and 2) of paramount importance for 
early stage eradication [2] [7]. 
Approximately 80% of all basal cell tumours 
appear in the facial area, with 25-30% of them on the 
nose [4]. This localisation is related to 2.5 times higher 
risk of relapse than any other and is considered to be 
a feature of high-risk carcinoma also because the 
area is associated with large anatomical features and 
difficulty in identifying tumour boundaries [4]. Risk 
factors include: 1) skin phototype, 2) prolonged 
exposure to ultraviolet radiation, and last but not least 
3) genetic predisposition, i.e. xeroderma 
pigmentosum, albinism, DNA repair deficiencies, 
family history of cancer, immunosuppression and 
exposure to carcinogenic substances (arsenic, 
polycyclic hydrocarbons) [2] [4]. 
The main goal in the treatment of basal cell 
carcinomas is the elimination of a tumour with 
maximum preservation of the normal function and 
structure of tissues [5]. Therefore, treatment decisions 
should be individualised according to the specific risk 
factors for each patient, but should also take into 
account the respective surgical security zones [5] [6] 
[7]. 
What is the most effective treatment approach 
for small to medium-sized tumours is controversial, 
and in most cases standard therapy is surgical 
excision [6][7]? The surgical approach should vary 
depending on the size, depth and location of the 
tumour, as well as the individual desire of each patient 
and his/her physician to be minimally traumatic and at 
the same time maximally effective [5] [6] [7]. 
Reconstruction of nasal defects after excision of skin 
tumours is almost always a challenge due to the 
complex three-dimensional structure of the nose and 
the need for the postoperative outcome to be 
aesthetically acceptable [4] [5]. 
It is currently believed that MMS or the so-
called Mohs micrographic surgery is a “gold standard” 
for the treatment of advanced and recurrent basal cell 
carcinomas, where the tumor and the surrounding 
skin are visualized microscopically, giving the clearest 
picture of pathological changes in the periphery of the 
resected tissue [8] [9]. 
In our two cases, island flap was performed 
with good results. Mohs micrographic surgery (MMS) 
should be a priority for tumours that show 
histologically infiltrative, sclerosing, micronodular or 
recurrent features [5] [8] [9]. Basal cell tumours 
measuring over 1 cm, aggressive histology and age of 
the patient over 80 years are thought to be the main 
MMS indicators [4] [5] [8] [9]. The clue of MMS is the 
complete control of the peripheral and deep resection 
fields, allowing re-excision and microscopic extension 
of the resection boundaries in a precisely defined 
surgical zone [8] [9]. This allows avoiding 
unnecessary removal of additional tissue, which is a 
common practice in conservative surgical techniques 
[5] [8] [9]. These properties make MMS a reliable 
treatment for carcinomas, especially when it comes to 
delicate areas such as the face [5] [8] [9]. The results 
from the studies conducted so far have shown that 
MMS provides the lowest relapse rate between 0 and 
2.5%, and therefore, this treatment should also be the 
first choice for relapsing basal cell carcinomas of the 
face [4] [5] [8] [9] [10]. 
In conclusion, island flap should not be a 
therapeutic option in patients with recurrent basal cell 
carcinomas and those who have undergone 
radiotherapy. Mohs micrographic surgery (MMS) in 
these patients ensures maximum safety, although the 
aesthetic results are less acceptable than in island 
flap. In patients with primary, untreated, small to 
medium basal cell carcinomas, island flap is a good 
therapeutic solution. 
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